Sunshine Biopharma Inc (SBFM)

[Midtermer]

A COVID-19 pill is poised to hit the U.S. market after a Food and Drug Administration panel narrowly recommended that Merck’s drug Molnupiravir be granted Emergency Use Authorization.

The FDA panel voted 13-10 that the antiviral drug’s benefits outweigh its risks. If the FDA grants the EUA, Molnupiravir could become first drug that Americans could take at home to treat the coronavirus.

There are major implications if the FDA grants approval to Molnupiravir. First, it signals a shift towards therapeutics as becoming a more prominent tool in the ongoing fight against Covid.

Second, it raises questions about the necessity of Covid vaccine mandates, particularly as the federal vaccine mandates continues to incur legal setbacks. If the mRNA therapies marketed as ‘vaccines’ continue to fail to halt the transmission of variants such as delta and omicron, then it will further call into question their efficacy and reliability.



Reality is....... 13-10 vote in a ‘pandemic’ means the pill is junk. Sunshine, where the heck are you????